Skip to main content
Search Query
Show Search
Home
Programs
Schedule
Schedule
News
Music News
NPR News
News From South Carolina
Music News
NPR News
News From South Carolina
Support WSSB
Volunteer
Volunteer
Listen & Connect
How to Listen & Connect
Facebook
Twitter
Instagram
Smart Speakers
How to Listen & Connect
Facebook
Twitter
Instagram
Smart Speakers
About Us
WSSB Staff
Address & Directions
Contact Us
Overview
PSA Guidelines
CPB Compliance
Code of Integrity
Diversity Statement
Governing Board
Online Public File
WSSB Staff
Address & Directions
Contact Us
Overview
PSA Guidelines
CPB Compliance
Code of Integrity
Diversity Statement
Governing Board
Online Public File
© 2026 WSSB
Menu
Show Search
Search Query
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00
0:00
Available On Air Stations
On Air
Now Playing
WSSB
All Streams
Home
Programs
Schedule
Schedule
News
Music News
NPR News
News From South Carolina
Music News
NPR News
News From South Carolina
Support WSSB
Volunteer
Volunteer
Listen & Connect
How to Listen & Connect
Facebook
Twitter
Instagram
Smart Speakers
How to Listen & Connect
Facebook
Twitter
Instagram
Smart Speakers
About Us
WSSB Staff
Address & Directions
Contact Us
Overview
PSA Guidelines
CPB Compliance
Code of Integrity
Diversity Statement
Governing Board
Online Public File
WSSB Staff
Address & Directions
Contact Us
Overview
PSA Guidelines
CPB Compliance
Code of Integrity
Diversity Statement
Governing Board
Online Public File
Search results for
Sort By
Relevance
Newest (Publish Date)
Oldest (Publish Date)
Search
Organizing online, Covid skeptics drive public health professionals from their jobs
At the same time Montana hospitals are seeing record numbers of Covid patients, county health officers are resigning or being forced out by elected officials who don't follow public health guidance.
Listen
•
5:06
Coronavirus FAQ: It's cold and flu season — and COVID season! How do I stay unsick?
Last winter the number of flu cases was pretty low — likely a result of COVID precautions people were taking. Does that mean we have fewer antibodies — and a greater risk of catching something now?
A bill to study reparations for slavery had momentum in Congress, but still no vote
Legislation to create a commission to study reparations faces steep odds in the evenly divided Congress. Advocates want the House to take up the bill, or for President Biden to act on his own.
Listen
•
4:29
Biodiesel is booming. It may help the climate, but there's a big environmental risk
Big oil companies are converting refineries to make "renewable diesel" from soybean oil or beef tallow. It's driven by policies intended to help the climate, but there's a big environmental risk.
Listen
•
5:04
Facebook is rebranding as Meta — but the app you use will still be called Facebook
The change comes as Facebook looks to recast its public image from battered social network to tech innovator focused on building the next generation of online interaction, known as the "metaverse."
Listen
•
4:24
A bad omen for Democrats and 4 other election night takeaways
The first big electoral night of the Biden presidency provided a bad omen for Democrats in 2022, and Republicans may have found a way to campaign in the post-Trump era.
How the Soviet Union's collapse explains the current Russia-Ukraine tension
To understand the friction between Russia and Ukraine, it's important to go back to 1991. Exactly 30 years ago this weekend, the Soviet Union formally dissolved and broke up into 15 separate nations.
Listen
•
5:37
Why Biden's new public lands chief has to 'walk a line' on climate policy
President Biden is under pressure to end all fossil fuel development on federal land in order to fight the climate crisis, yet the influential industry still expects new drilling opportunities.
Families are in distress after the first month without the expanded child tax credit
January is the first month since July 2021 that more than 36 million families in the U.S. did not receive money from the expanded child tax credit program. For some, the consequences are already dire.
Why remdesivir, a highly effective COVID treatment, is a last resort for providers
The antiviral infusion was just revived as an early treatment for COVID patients. But the drug is relatively expensive and hard to administer, relegating it to what some are calling "stopgap" status.
Listen
•
4:03
Previous
3,200 of 4,582
Next